Sanders Morris Harris’s Regenxbio RGNX Stock Holding History

Sanders Morris Harris’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-7,700	Closed	-$300K	–	191
2020 Q1	$300K	Hold	7,700	–	–	0.29%	81
2019 Q4	$300K	Buy	+7,700	New	+$304K	0.07%	222

Other funds holding RGNX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

ACM

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sanders Morris Harris's RGNX Position: Q2 2020 in Review

Sanders Morris Harris sold out of Regenxbio (RGNX) in Q2 2020, closing a stake of 7,700 shares — an estimated $300K sold.

Sanders Morris Harris first reported a position in RGNX in Q4 2019 and held it in 2 quarters. The position peaked at $300K in Q1 2020. 179 funds tracked by Wall St. Rank hold RGNX as of Q2 2020.

Sanders Morris Harris reported no remaining Regenxbio position as of Q2 2020 after selling out during the quarter.
Sanders Morris Harris sold 7,700 Regenxbio shares in Q2 2020, an estimated $300K.
Sanders Morris Harris first reported a position in Regenxbio in Q4 2019 and held it in 2 quarters.
Sanders Morris Harris's Regenxbio position peaked at $300K in Q1 2020.
179 funds tracked by Wall St. Rank held Regenxbio as of Q2 2020.

Based on Sanders Morris Harris's 13F filing for Q2 2020, filed 9 Jul 2020.